Feature Channels:

Diabetes

Add to Favorites Subscribe Share
Signature-Vertical.png
Released:
17-Jan-2020 8:05 AM EST
mmc-logo.gif

Hohe Insulinkosten sind für Diabetespatienten lebensbedrohlich

Mayo Clinic

Die am häufigsten verwendeten Formen von Insulin kosten in den USA 10-mal mehr als in jedem anderen Industrieland, wie aus einem Kommentar in Mayo Clinic Proceedings hervorgeht.

Channels: Diabetes, Healthcare, Pharmaceuticals, Public Health, Government/Law, All Journal News,

Released:
14-Jan-2020 1:45 PM EST
Research Results
mmc-logo.gif

Le coût élevé de l'insuline a des répercussions sur la vie ou la mort des patients diabétiques

Mayo Clinic

Les formes d'insuline les plus couramment utilisées coûtent 10 fois plus cher aux États-Unis que dans tous les autres pays développés, selon un commentaire publié dans la revue Mayo Clinic Proceedings.

Channels: Diabetes, Healthcare, Pharmaceuticals, All Journal News,

Released:
14-Jan-2020 12:25 PM EST
Research Results
mmc-logo.gif

آثار ارتفاع تكلفة الأنسولين على حياة مرضى السكري

Mayo Clinic

تزيد تكلفة أشكال الأنسولين الأكثر استخدامًا في الولايات المتحدة بمقدار 10 مرات عن أي دولة من الدول المتقدمة الأخرى، وفقًا لتعليق في مجلة Mayo Clinic Proceedings. وبسبب هذه التكلفة الباهظة، يلجأ بعض مرضى السكري من النوع الأول في الولايات المتحدة إلى الاقتصاد في كمية الأنسولين التي يستخدمونها، الأمر الذي له تداعيات تهدد حياتهم.

Channels: Diabetes, Healthcare, Pharmaceuticals, All Journal News,

Released:
14-Jan-2020 12:10 PM EST
Research Results
mmc-logo.gif

Custo elevado da insulina pode significar vida ou morte para pacientes diabéticos

Mayo Clinic

As formas mais comumente usadas de insulina custam 10 vezes mais nos EUA que em qualquer outro país desenvolvido, de acordo com um comentário publicado na Mayo Clinic Proceedings.

Channels: Diabetes, All Journal News,

Released:
14-Jan-2020 11:05 AM EST
Research Results
Newswise: Endocrine Society awards Baxter Prize to diabetes treatment entrepreneur

Endocrine Society awards Baxter Prize to diabetes treatment entrepreneur

Endocrine Society

Researcher Daniel J. Drucker has been awarded the Endocrine Society’s John D. Baxter Prize for Entrepreneurship for his contributions to diabetes treatment, the Society announced today.

Channels: Diabetes, Healthcare, In the Workplace,

Released:
14-Jan-2020 9:35 AM EST
Research Results
wzn-logo.png

Weizmann Scientists Devise New Algorithm that Predicts Gestational Diabetes

Weizmann Institute of Science

Using machine learning to analyze data on nearly 600,000 pregnancies, researchers devised an algorithm that identified nine parameters – out of more than 2,000 analyzed – that can predict which women are at risk of gestational diabetes. The parameters can identify risk early in – even before – pregnancy, enabling early intervention.

Channels: Artificial Intelligence, Diabetes, Healthcare, Nutrition, OBGYN, Technology, Women's Health, Nature (journal), All Journal News,

Released:
13-Jan-2020 2:25 PM EST
Announcement
Newswise: Dehydrated, low on sugar or at risk of skin infection? Wearable sensor made by NUS researchers can tell from your sweat

Dehydrated, low on sugar or at risk of skin infection? Wearable sensor made by NUS researchers can tell from your sweat

National University of Singapore

A team of NUS researchers have come up with the pH Watch, an ‘add-on’ to a wearable health monitoring gadget that can tell users about the condition of their health from their sweat pH.

Channels: Children's Health, Dermatology, Diabetes, Infectious Diseases,

Released:
13-Jan-2020 5:20 AM EST
Research Results
mmc-logo.gif

تظهر دراسة على قطاع من الناس أن داء السكري يمكن ان يكون عاملاً مستقلا في نشوء فشل القلب

Mayo Clinic

تعتبر مشاكل القلب من التطورات الشائعة لمرضى السكري. وفي الولايات المتحدة فإن حوالي 33٪ من الأشخاص الذين يتلقون علاجًا في المستشفى لفشل القلب يعانون من داء السكري. قد ينتج في بعض الأحيان فشل القلب عن حالات مصاحبة ، مثل الإصابة بإرتفاع ضغط الدم أو أمراض القلب التاجية.

Channels: Cardiovascular Health, Diabetes, Healthcare, Heart Disease, All Journal News,

Released:
10-Jan-2020 1:25 PM EST
Research Results
JOS-logo.gif

New Closed-Loop System Offers Promise as Novel Treatment for Post-Bariatric Hypoglycemia

Joslin Diabetes Center

Post-bariatric hypoglycemia is a profoundly life-altering condition for patients. Having unpredictable hypoglycemia that people can't detect is really an unsafe situation. Researchers at Joslin Diabetes Center and Harvard John A. Paulson School of Engineering and Applied Sciences have developed a closed-loop system that automatically provides patients with an appropriate, as-needed dose of liquid glucagon to treat this condition.

Channels: Diabetes, Digestive Disorders, Healthcare, Surgery, Technology, All Journal News,

Released:
9-Jan-2020 2:25 PM EST
Research Results


18.09329